benzophenones bromfenac 2-amino-3-(4-bromobenzoyl)benzeneacetic acid 333.000 334.16500 Amfenac in which the the hydrogen at the 4 position of the benzoyl group is substituted by bromine. It is used for the management of ocular pain and treatment of postoperative inflammation in patients who have undergone cataract extraction. It was withdrawn from the US market in 1998, following concerns over off-label abuse and hepatic failure. Beilstein:8335547 C15H12BrNO3 CAS:91714-94-2 CHEBI:240107 DrugBank:DB00963 Drug_Central:401 InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19) KEGG:D07541 LINCS:LSM-5585 Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1 Patent:EP221753 Patent:US4683242 Wikipedia:Bromfenac ZBPLOVFIXSTCRZ-UHFFFAOYSA-N [2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid [2-amino-3-(4-bromobenzoyl)phenyl]acetic acid bromfenac bromfenaco bromfenacum chebi_ontology aromatic amino acid organobromine compound substituted aniline